News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
859,442 Results
Type
Article (87296)
Company Profile (694)
Press Release (771433)
Multimedia
Podcasts (174)
Webinars (28)
Section
Business (233000)
Career Advice (4138)
Deals (39796)
Drug Delivery (137)
Drug Development (91188)
Employer Resources (203)
FDA (18249)
Job Trends (17398)
News (397215)
Policy (39896)
Tag
Academia (3003)
Academic (1)
Accelerated approval (18)
Adcomms (31)
Allergies (121)
Alliances (56967)
ALS (145)
Alzheimer's disease (1672)
Antibody-drug conjugate (ADC) (240)
Approvals (18295)
Artificial intelligence (455)
Autoimmune disease (73)
Automation (27)
Bankruptcy (404)
Best Places to Work (12616)
BIOSECURE Act (23)
Biosimilars (161)
Biotechnology (452)
Bladder cancer (131)
Brain cancer (51)
Breast cancer (500)
Cancer (3914)
Cardiovascular disease (331)
Career advice (3557)
Career pathing (38)
CAR-T (243)
CDC (52)
Cell therapy (664)
Cervical cancer (32)
Clinical research (75459)
Collaboration (1378)
Company closure (4)
Compensation (929)
Complete response letters (56)
COVID-19 (2952)
CRISPR (81)
C-suite (584)
Cystic fibrosis (134)
Data (4512)
Decentralized trials (2)
Denatured (62)
Depression (105)
Diabetes (432)
Diagnostics (7072)
Digital health (34)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (206)
Drug pricing (177)
Drug shortages (32)
Duchenne muscular dystrophy (202)
Earnings (98688)
Editorial (52)
Employer branding (25)
Employer resources (172)
Events (132802)
Executive appointments (963)
FDA (20693)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (15)
Funding (1230)
Gene editing (173)
Generative AI (39)
Gene therapy (541)
GLP-1 (989)
Government (5360)
Grass and pollen (6)
Guidances (342)
Healthcare (20906)
HIV (44)
Huntington's disease (38)
IgA nephropathy (62)
Immunology and inflammation (233)
Immuno-oncology (21)
Indications (53)
Infectious disease (3181)
Inflammatory bowel disease (187)
Inflation Reduction Act (15)
Influenza (97)
Intellectual property (190)
Interviews (815)
IPO (17920)
IRA (56)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (15)
Labor market (78)
Layoffs (634)
Leadership (35)
Legal (10134)
Liver cancer (92)
Longevity (12)
Lung cancer (566)
Lymphoma (266)
Machine learning (30)
Management (66)
Manufacturing (622)
MASH (139)
Medical device (14829)
Medtech (14852)
Mergers & acquisitions (22730)
Metabolic disorders (1117)
Multiple sclerosis (136)
NASH (23)
Neurodegenerative disease (223)
Neuropsychiatric disorders (57)
Neuroscience (2685)
NextGen: Class of 2025 (7673)
Non-profit (5092)
Now hiring (57)
Obesity (534)
Opinion (311)
Ovarian cancer (135)
Pain (158)
Pancreatic cancer (172)
Parkinson's disease (234)
Partnered (29)
Patents (417)
Patient recruitment (312)
Peanut (57)
People (66188)
Pharmaceutical (134)
Pharmacy benefit managers (26)
Phase I (23288)
Phase II (32767)
Phase III (24678)
Pipeline (2718)
Policy (288)
Postmarket research (3553)
Preclinical (10495)
Press Release (72)
Prostate cancer (195)
Psychedelics (50)
Radiopharmaceuticals (278)
Rare diseases (663)
Real estate (7420)
Recruiting (79)
Regulatory (27965)
Reports (65)
Research institute (2683)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (66)
Schizophrenia (133)
Series A (209)
Series B (156)
Service/supplier (27)
Sickle cell disease (81)
Special edition (25)
Spinal muscular atrophy (169)
Sponsored (40)
Startups (4319)
State (2)
Stomach cancer (15)
Supply chain (94)
Tariffs (90)
The Weekly (110)
Vaccines (1032)
Venture capital (67)
Weight loss (371)
Women's health (59)
Worklife (21)
Date
Today (138)
Last 7 days (708)
Last 30 days (2579)
Last 365 days (32171)
2025 (25560)
2024 (37560)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1279)
Alabama (80)
Alaska (7)
Arizona (300)
Arkansas (14)
Asia (50947)
Australia (8956)
California (9399)
Canada (2846)
China (896)
Colorado (399)
Connecticut (406)
Delaware (262)
Europe (116926)
Florida (1381)
Georgia (307)
Hawaii (3)
Idaho (67)
Illinois (778)
India (49)
Indiana (449)
Iowa (20)
Japan (322)
Kansas (124)
Kentucky (36)
Louisiana (20)
Maine (73)
Maryland (1264)
Massachusetts (7032)
Michigan (293)
Minnesota (553)
Mississippi (4)
Missouri (111)
Montana (32)
Nebraska (26)
Nevada (107)
New Hampshire (75)
New Jersey (2601)
New Mexico (31)
New York (2560)
North Carolina (1400)
North Dakota (10)
Northern California (4282)
Ohio (286)
Oklahoma (22)
Oregon (48)
Pennsylvania (1961)
Puerto Rico (19)
Rhode Island (45)
South America (1655)
South Carolina (47)
South Dakota (1)
Southern California (3580)
Tennessee (147)
Texas (1460)
United States (34539)
Utah (277)
Virginia (235)
Washington D.C. (80)
Washington State (809)
West Virginia (4)
Wisconsin (81)
Wyoming (1)
859,442 Results for "adicet bio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adicet Bio, Inc. Announces $80 Million Registered Direct Offering
October 8, 2025
·
3 min read
Press Releases
Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis (RA)
October 16, 2025
·
5 min read
Press Releases
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - September 30, 2025
October 1, 2025
·
1 min read
Press Releases
Adicet Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 2, 2025
·
1 min read
Press Releases
Adicet Bio Announces Positive Preliminary Data from ADI-001 Phase 1 Study in Patients with Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)
October 8, 2025
·
12 min read
Press Releases
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - August 29, 2025
September 1, 2025
·
1 min read
Press Releases
Adicet Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
August 8, 2025
·
10 min read
Press Releases
Adicet Bio to Participate in a Fireside Chat at the 45th Annual Canaccord Genuity Growth Conference
August 6, 2025
·
1 min read
Press Releases
Adicet Bio Announces First Systemic Sclerosis (SSc) Patient Dosed in Ongoing Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases
July 25, 2025
·
5 min read
Press Releases
Adicet Bio to Participate in a Fireside Chat at the 2025 Jefferies Global Healthcare Conference
May 22, 2025
·
1 min read
1 of 85,945
Next
